Table 4 Area under the ROC curve analysis of insulin resistance surrogate indices for hypertension prediction by sex.
AUC* | SE (%95 CI) | P-value | Sensitivity (%) | Specificity (%) | Cutoff point | Youden index | ||
|---|---|---|---|---|---|---|---|---|
TyG Index | Overall | 0.623 | 0.02 (0.58–0.67) | < 0.001 | 62 | 60 | 8.88 | 0.22 |
Male | 0.642 | 0.03 (0.59–0.69) | < 0.001 | 68 | 58 | 8.87 | 0.26 | |
Female | 0.569 | 0.4 (0.5–0.64) | 0.07 | 65 | 50 | 8.72 | 0.15 | |
VAI | Overall | 0.568 | 0.02 (0.52–0.61) | < 0.001 | 77 | 36 | 1.53 | 0.13 |
Male | 0.614 | 0.03 (0.56–0.67) | < 0.001 | 66 | 46 | 1.76 | 0.12 | |
Female | 0.53 | 0.04 (0.46–0.61) | 0.43 | 53 | 56 | 2.36 | 0.09 | |
LAP | Overall | 0.624 | 0.02 (0.58–0.66) | < 0.001 | 87 | 35 | 35.72 | 0.22 |
Male | 0.667 | 0.025(0.62–0.72) | < 0.001 | 85 | 55 | 35.7 | 0.3 | |
Female | 0.586 | 0.04 (0.52–0.66) | 0.024 | 92 | 23 | 33.98 | 0.15 | |
MET-IR | Overall | 0.652 | 0.02 (0.61–0.69) | < 0.001 | 94 | 30 | 35.7 | 0.24 |
Male | 0.707 | 0.024(0.66–0.75) | < 0.001 | 94 | 63 | 35.7 | 0.31 | |
Female | 0.606 | 0.3 (0.54–0.67) | 0.007 | 67 | 51 | 41.88 | 0.18 | |
TYG-WC | Overall | 0.647 | 0.02 (0.61–0.69) | 0.003 | 90 | 34 | 783.4 | 0.24 |
Male | 0.695 | 0.024 (0.65–0.74) | < 0.001 | 80 | 53 | 826.2 | 0.33 | |
Female | 0.599 | 0.034(0.53–0.67) | 0.01 | 92 | 27 | 776.5 | 0.19 | |
TYG-BMI | Overall | 0.660 | 0.02 (0.62–0.7) | < 0.001 | 79 | 47 | 227.4 | 0.26 |
Male | 0.712 | 0.024(0.66–0.76) | < 0.001 | 76 | 58 | 227.5 | 0.34 | |
Female | 0.623 | 0.033(0.56–0.69) | 0.001 | 97 | 24 | 210.35 | 0.21 | |
TG/HDL | Overall | 0.591 | 0.02 (0.55–0.64) | < 0.001 | 65 | 52 | 2.67 | 0.18 |
Male | 0.612 | 0.03 (0.56–0.67) | < 0.001 | 71 | 52 | 2.7 | 0.19 | |
Female | 0.534 | 0.04 (0.46–0.61) | 0.39 | 55 | 58 | 2.67 | 0.13 | |
AIP | Overall | 0.591 | 0.023 (0.55–0.64) | < 0.001 | 65 | 52 | 0.07 | 0.18 |
Male | 0.612 | 0.03 (0.56–0.67) | < 0.001 | 71 | 48 | 0.07 | 0.19 | |
Female | 0.534 | 0.04 (0.46–0.61) | 0.038 | 55 | 58 | 0.07 | 0.13 | |